Oncology Pharma IncOver The Counter Market:ONPH
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0000
- Day Range
- 52 Week Range
- Volume3,269
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Time | Volume | ONPH |
|---|---|---|
| 12:42 ET | 275 | 1E-06 |
| 01:20 ET | 2000 | 1E-06 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Oncology Pharma Inc | 40.0 | 0.0x | --- |
Nunzia Pharmaceutical Corp | 430.0 | 0.0x | --- |
Gelstat Corp | 210.0K | -0.1x | --- |
Lucy Scientific Discovery Inc | 880.0 | 0.0x | --- |
Petlife Pharmaceuticals Inc | 19.7K | 0.0x | --- |
Pilot Therapeutics Holdings Inc | 1.2K | 0.0x | --- |
Company Information
Oncology Pharma, Inc. is an oncology company. The Company is focused on licensing, developing, manufacturing and commercializing therapeutics. The Company’s research, development, and commercialization of therapeutic drugs and medical devices designed for the treatment of many types of cancers. The Company offers a portfolio, such as Nanosmart Pharmaceuticals Inc. (Nanosmart Pharmaceuticals). The Company’s NanoSmart platform technology is a human-derived, antinuclear antibody (ANA) that targets areas of necrosis present in solid tumors. Its anti-cancer drugs in combination with medications, for treating a variety of cancers, such as breast, ovarian, lung, bladder, Kaposi's sarcoma, lymphoma and acute lymphocytic leukemia is doxorubicin. Its portfolio also includes Connect2Med, Sybleu, Inc. and Regen.
Contact Information
- Headquarters
- One Sansome Street,, Suite 3500SAN FRANCISCO, CA, United States 94104
- Phone
- 415-869-1036
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $40.00 |
|---|---|
Revenue (TTM) | $29.5K |
Shares Outstanding | 38.6M |
Oncology Pharma Inc does not pay a dividend. | |
Beta | -3.04 |
EPS | $-20,154,790.00 |
Book Value | --- |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -75,237.89% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
